Case Form
Find Out if You Potentially Qualify for a Financial Reward by filling out the form.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Specifically, on May 7, 2024, Treace released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approximately $20 million, citing “increased use of MIS Osteotomy solutions and more competition from knockoffs of [the Company’s] Lapiplasty products.”